Clinical Trial Update: AbataCept for the Treatment of Immune-cHeckpoint Inhibitors Induced mYocarditiS [Phase 2]

View source ↗

Summary

Phase 2 trial of AbataCept for myocarditis induced by immune checkpoint inhibitors; the study is currently ACTIVE_NOT_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocarditis

Drugs mentioned

• Abatacept (abatacept)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Myocarditis | Phase 2 | Status: ACTIVE_NOT_RECRUITING